|Day's Range||48.35 - 49.02|
|52 Week Range||37.38 - 49.59|
|PE Ratio (TTM)||50.45|
|Dividend & Yield||1.06 (2.18%)|
|1y Target Est||N/A|
Boston Scientific, Abbott Laboratories and Medtronic are unlikely to engage Philips in a bidding war for Spectranetics, an analyst says.
Each year, more than 23,000 people die in the U.S. as a result of bacterial infections that are resistant to antibiotics – the equivalent of a Boeing 747 crashing each week. Worse, there are at least 2 million people each year who acquire serious infections by bacteria resistant to antibiotics.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Abbott Laboratories Here are 5 ETFs with the largest exposure to ABT-US. Comparing the performance and risk of Abbott Laboratories with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)